Global X Management Company’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$1.67M Buy
5,758
+744
+15% +$209K 0.03% 345
2018
Q1
$1.37M Buy
5,014
+586
+13% +$182K 0.03% 343
2017
Q4
$1.41M Buy
4,428
+492
+13% +$158K 0.03% 290
2017
Q3
$1.23M Buy
3,936
+291
+8% +$86.2K 0.03% 312
2017
Q2
$989K Buy
3,645
+506
+16% +$134K 0.03% 352
2017
Q1
$858K Buy
3,139
+641
+26% +$181K 0.03% 351
2016
Q4
$708K Buy
2,498
+1,429
+134% +$424K 0.03% 321
2016
Q3
$335K Buy
1,069
+801
+299% +$237K 0.01% 434
2016
Q2
$65K Buy
268
+230
+605% +$60.6K ﹤0.01% 632
2016
Q1
$10K Sell
38
-10
-21% -$2.64K ﹤0.01% 868
2015
Q4
$15K Sell
48
-4
-8% -$1.15K ﹤0.01% 532
2015
Q3
$15K Buy
52
+48
+1,200% +$15.9K ﹤0.01% 528
2015
Q2
$2K Buy
+4
New +$1.6K ﹤0.01% 854

Other funds holding BIIB

Global X Management Company's BIIB Position: Q2 2018 in Review

Global X Management Company increased its Biogen (BIIB) stake by 15% in Q2 2018, buying an estimated $209K and bringing the position to 5,758 shares worth $1.67M. The position accounts for 0.03% of the portfolio, ranked #345.

Global X Management Company first reported a position in BIIB in Q2 2015 and has held it in 13 quarters since. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

  • Global X Management Company held 5,758 shares of Biogen worth $1.67M as of Q2 2018.
  • Global X Management Company bought 744 Biogen shares in Q2 2018, an estimated $209K.
  • Biogen made up 0.03% of Global X Management Company's portfolio in Q2 2018, its #345 holding.
  • Global X Management Company first reported a position in Biogen in Q2 2015 and has held it in 13 quarters since.
  • 1,098 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.